Condensed Consolidated Statements of Income - USD ($) $ in Millions	3 Months Ended
	Mar. 29, 2024	Mar. 31, 2023
Net sales	$ 467.8	$ 424.6
Cost of sales	303.8	374.8
Gross profit	164.0	49.8
Selling, general and administrative expenses	136.9	118.0
Research and development expenses	27.9	28.3
Restructuring charges, net	10.2	1.2
Separation Costs	6.7	4.9
Operating loss	(17.7)	(102.6)
Interest expense	59.1	162.0
Interest income	(6.8)	(4.7)
Other income (expense), net	3.7	(14.6)
Reorganization items, net	0.0	(5.6)
Loss from continuing operations before income taxes	(66.3)	(280.1)
Income tax benefit	(0.7)	(30.8)
Loss from continuing operations	(65.6)	(249.3)
Income from discontinued operations, net of income taxes	0.2	0.0
Net loss	$ (65.4)	$ (249.3)
Basic (loss) income per share (Note 6):
Loss from continuing operations	$ (3.33)	$ (18.93)
Income from discontinued operations	0.01	0
Net loss	$ (3.32)	$ (18.93)
Basic weighted-averaged shares outstanding (in shares)	19.7	13,200,000
Diluted (loss) income per share (Note 6):
Loss from continuing operations	$ (3.33)	$ (18.93)
Income from discontinued operations	0.01	0
Net loss	$ (3.32)	$ (18.93)
Diluted weighted-average shares outstanding (in shares)		13,200,000
Retained Earnings (Deficit)
Net loss	$ (65.4)	$ (249.3)